Page last updated: 2024-10-27

gabexate and Pemphigus

gabexate has been researched along with Pemphigus in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Pemphigus: Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naito, K1

Other Studies

1 other study available for gabexate and Pemphigus

ArticleYear
[The identification of inhibitors of acantholysis of pemphigus vulgaris].
    Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology, 1987, Volume: 97, Issue:11

    Topics: Acantholysis; Animals; Fibrinolysin; Gabexate; Guanidines; Humans; Mice; Mice, Inbred BALB C; Pemphi

1987